Acurx Pharmaceuticals (ACXP) Misses Q3 EPS by 2c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q3 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Fort Technology posts 49% revenue rise in first half of 2026
• BMO Capital Reiterates Outperform Rating on Workday (WDAY)